INCREASED IRON-RELATED MRI CONTRAST IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE

被引:270
作者
GORELL, JM
ORDIDGE, RJ
BROWN, GG
DENIAU, JC
BUDERER, NM
HELPERN, JA
机构
[1] HENRY FORD HOSP,DEPT PSYCHIAT,DETROIT,MI 48202
[2] HENRY FORD HOSP,DIV BIOSTAT & RES EPIDEMIOL,DETROIT,MI 48202
[3] HLTH SCI CTR,DETROIT,MI 48202
[4] OAKLAND UNIV,DEPT PHYS,ROCHESTER,MI
关键词
D O I
10.1212/WNL.45.6.1138
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Elevated iron levels in the substantia nigra (SN) of the brain in Parkinson's disease (PD) may mediate lipid peroxidative reactions, promoting SN neuronal death. To assess SN iron accumulation in living PD patients and its relation to motor performance, we measured, in 13 nondemented PD patients and 10 normal control subjects, simple reaction time (SRT) and simple movement time (SMT), followed by head MRI in a 3-tesla system, We measured T-2 and T-2* in the right and left SN of all subjects and calculated R(2)', the relaxation rate due to local magnetic field inhomogeneities, from these values. Asymmetries of 1/T-2 (R(2)), 1/T-2* (R(2)*), or R(2)' versus asymmetries of SRT and SMT were assessed in eight PD subjects who had not taken anti-PD medication(s) for 12 hours. The average of right and left SN values for R(2) was lower, and R(2)* and R(2)' were higher, in PD patients than in controls (R(2), p = 0.046; R(2)*, p = 0.001; R(2)', p < 0.001). R(2)' best predicted group differences. The asymmetry of SRT performance was highly correlated with asymmetries of SN R(2)* (0.91; p = 0.001) and R(2)' (0.72; p = 0.03). These results strongly suggest that the increases in iron levels seen postmortem in the SN in PD are reflected in increased iron-related MRI contrast at 3 tesla in living PD patients. Correlations with motor performance in PD suggest that the clinical severity of PD may be related to SN iron accumulation.
引用
收藏
页码:1138 / 1143
页数:6
相关论文
共 32 条
[11]   BASAL LIPID-PEROXIDATION IN SUBSTANTIA NIGRA IS INCREASED IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
CARTER, CJ ;
WELLS, FR ;
JAVOYAGID, F ;
AGID, Y ;
LEES, A ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) :381-389
[12]  
DEXTER DT, 1993, ADV NEUROL, V60, P273
[13]  
DRAYER B, 1986, AM J NEURORADIOL, V7, P373
[14]   MAGNETIC-RESONANCE-IMAGING OF THE MIDBRAIN IN PARKINSONS-DISEASE [J].
DUGUID, JR ;
DELAPAZ, R ;
DEGROOT, J .
ANNALS OF NEUROLOGY, 1986, 20 (06) :744-747
[15]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[16]  
GORELL JM, 1989, ALZHEIMERS AND PARKINSONS DISEASES /, P355
[17]  
Hays W. L, 1973, STATISTICS SOCIAL SC, P683
[18]   A COMPARATIVE-STUDY OF SIMPLE AND CHOICE-REACTION TIME IN PARKINSONS, HUNTINGTONS AND CEREBELLAR DISEASE [J].
JAHANSHAHI, M ;
BROWN, RG ;
MARSDEN, CD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (11) :1169-1177
[19]   GLUTATHIONE-PEROXIDASE ACTIVITY IN PARKINSONS-DISEASE BRAIN [J].
KISH, SJ ;
MORITO, C ;
HORNYKIEWICZ, O .
NEUROSCIENCE LETTERS, 1985, 58 (03) :343-346
[20]  
Lang A., 1990, THERAPY PARKINSONS D, P3